Advanced-Stage Polycystic Kidney Disease with Extrarenal Complications in a 55-Year-Old Woman: A Case Report

Authors

  • Hillery Sihotang Universitas Lampung
  • Hotmen Sijabat Ilmu Penyakit Dalam, RSUD DR. H. Abdul Moeloek Provinsi Lampung

DOI:

https://doi.org/10.53089/medula.v15i2.1606

Keywords:

Keywords: Chronic kidney disease, hepatic cysts, end-stage renal disease, PKD

Abstract

Polycystic Kidney Disease (PKD) is an inherited kidney disorder characterized by the formation of multiple fluid-filled cysts in the kidneys, frequently involving other organs such as the liver. It is a progressive condition that can lead to end-stage renal disease (ESRD). This case report aims to explore the clinical course and management approach of a PKD patient with poor follow-up adherence since diagnosis. A 55-year-old female with a diagnosis of PKD since 2009 presented with abdominal enlargement, fatigue, and right upper quadrant discomfort. Despite a positive family history, the patient did not receive regular monitoring and relied on herbal remedies. Over 16 years, disease progression was marked by significant increases in serum urea and creatinine, development of multiple renal and hepatic cysts, and progression to chronic kidney disease (CKD) stage 4–5. The patient currently suffers from hepatic cyst complications and ESRD. This case highlights the accelerated progression of PKD in the absence of consistent clinical monitoring and early therapeutic intervention. It underscores the importance of early detection, regular renal function evaluation, patient and family education, and supportive care. Planning for renal replacement therapy and genetic screening of offspring are crucial to mitigate disease progression and improve outcomes in PKD patients.

Author Biography

Hotmen Sijabat, Ilmu Penyakit Dalam, RSUD DR. H. Abdul Moeloek Provinsi Lampung

 

 

References

Cornec-Le Gall E, Alam A, Perrone RD. Autosomal dominant polycystic kidney disease. Lancet. 2019;393(10174):919–935.

Chebib FT, Torres VE. Autosomal Dominant Polycystic Kidney Disease: Core Curriculum 2016. Am J Kidney Dis. 2016;67(5):792–810.

Partiningrum DL, Harumsari S, Cayami FK, Lestariningsih L, Pals G, Faradz SMH. Clinical evaluation and mutation analysis in Indonesian autosomal dominant polycystic kidney disease. Pak J Med Health Sci. 2019;13(3):908–913.

Torres VE, Chapman AB, Devuyst O, Gansevoort RT, Grantham JJ, Higashihara E, et al. Tolvaptan in patients with autosomal dominant polycystic kidney disease. N Engl J Med. 2012;367(25):2407–2418.

Djajapranata KM, Tjempakasari A. Autosomal dominant polycystic kidney disease (ADPKD) with multiple complications: Management challenges. Narra J. 2024;4(1):1–8.

Hustrini NM, Susalit E, Lydia A, Marbun MBH, Syafiq M, Yassir, et al. The etiology of kidney failure in Indonesia: A multicenter study in tertiary-care centers in Jakarta. Ann Glob Health. 2023;89(1):1–13.

Chapman AB, Devuyst O, Eckardt KU, Gansevoort RT, Harris T, Horie S, et al. Autosomal-dominant polycystic kidney disease (ADPKD): Executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2021;88(1):17–27.

Germino GG, Guay-Woodford LM. Polycystic Kidney Disease. In: Taal MW, Chertow GM, Marsden PA, Skorecki K, Yu ASL, Brenner BM, editors. Chronic Renal Disease. 2nd ed. Philadelphia: Elsevier; 2015. p. 484–500.

Published

2025-05-16

How to Cite

Sihotang, H., & Sijabat, H. (2025). Advanced-Stage Polycystic Kidney Disease with Extrarenal Complications in a 55-Year-Old Woman: A Case Report. Medical Profession Journal of Lampung, 15(2), 192-197. https://doi.org/10.53089/medula.v15i2.1606

Issue

Section

Artikel